Drop in cancer diagnosis during the COVID-19 pandemic in Denmark: assessment of impact during 2020

Acta Oncol. 2022 May;61(5):658-661. doi: 10.1080/0284186X.2021.2024879. Epub 2022 Jan 12.

Authors

Charlotte Wessel Skovlund¹, Søren Friis¹, Jane Christensen^{1

2}, Mef Christina Nilbert^{3

4}, Lina Steinrud Mørch¹

Affiliations

¹ Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
² Statistics and Data Analysis, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
³ Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
⁴ Hvidovre Hospital, Clinical Research Center, University of Copenhagen, Denmark.

PMID: 35020549
DOI: 10.1080/0284186X.2021.2024879

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / epidemiology
Denmark / epidemiology
Humans
Neoplasms* / diagnosis
Neoplasms* / epidemiology
Pandemics
SARS-CoV-2